Trials / Completed
CompletedNCT03037788
Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis
Pharmacokinetics, Local and Systemic Tolerability and Local Efficacy of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in a Placebo Controlled, Double Blind Study in Subjects With Axillary Hyperhidrosis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Dr. August Wolff GmbH & Co. KG Arzneimittel · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to assess the safety, tolerability, pharmacokinetics (PK) and efficacy of escalating concentrations of GPB in subjects with axillary hyperhidrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | WO3979 | Application of cream to each axilla |
| DRUG | WO3970 | Application of cream to each axilla |
| DRUG | WO3992 | Application of cream to each axilla |
| DRUG | Placebo (WO3988) | Application of cream to each axilla |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-06-01
- Completion
- 2017-07-01
- First posted
- 2017-01-31
- Last updated
- 2020-04-08
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03037788. Inclusion in this directory is not an endorsement.